Integrating the MicroRNome into the study of lung disease.
Over the last 15 years, investigators have identified small noncoding RNAs as regulators of gene expression. One type of noncoding RNAs are termed microRNAs (miRNAs). miRNAs are evolutionary conserved, approximately 22-nucleotide single-stranded RNAs that target genes by inducing mRNA degradation or by inhibiting translation. miRNAs are implicated in many critical cellular processes, including apoptosis, proliferation, and differentiation. Furthermore, it is estimated that miRNAs may be responsible for regulating the expression of nearly one-third of the human genome. Despite the identification of greater than 500 mature miRNAs, very little is known about their biological functions and functional targets. In the last 5 years, researchers have increasingly focused on the functional relevance and role that miRNAs play in the pathogenesis of human disease. miRNAs are known to be important in solid organ and hematological malignancies, heart disease, as potential modulators of the immune response, and organ development. It is anticipated that miRNA analysis will emerge as an important complement to proteomic and genomic studies to further our understanding of disease pathogenesis. Despite the application of genomics and proteomics to the study of human lung disease, few studies have examined miRNA expression. This perspective is not meant to be an exhaustive review of miRNA biology but will provide an overview of both miRNA biogenesis and our current understanding of the role of miRNAs in lung disease as well as a perspective on the importance of integrating this analysis as a tool for identifying and understanding the biological pathways in lung-disease pathogenesis.
Nana-Sinkam
Serge P
SP
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Ohio State University Medical Center, Columbus, OH 43210, USA. Patrick.Nana-Sinkam@osumc.edu
Hunter
Melissa G
MG
Nuovo
Gerard J
GJ
Schmittgen
Thomas D
TD
Gelinas
Richard
R
Galas
David
D
Marsh
Clay B
CB
D001402:B-Lymphocytes / Q000502:physiology; D044127:Epigenesis, Genetic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D008171:Lung Diseases / Q000378:metabolism / Q000503:physiopathology*; D035683:MicroRNAs / Q000187:drug effects / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D013601:T-Lymphocytes / Q000502:physiology
C524942:MIRN155 microRNA, human; D035683:MicroRNAs
BMC Genomics. 2007 Jul 17;8:240
17640343
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
14973191
Oncogene. 2008 Apr 3;27(15):2128-36
17968323
Oncogene. 2007 Sep 6;26(41):6099-105
17384677
Nat Med. 2007 May;13(5):613-8
17468766
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9740-4
15210942
Semin Cancer Biol. 2008 Apr;18(2):131-40
18291670
J Cell Physiol. 2007 Nov;213(2):412-9
17674365
Trends Genet. 2006 Mar;22(3):165-73
16446010
Immunity. 2007 Dec;27(6):847-59
18055230
Cell Cycle. 2006 Oct;5(19):2220-2
17012846
BMC Genomics. 2007 Jun 12;8:166
17565689
Cancer Cell. 2008 Jan;13(1):48-57
18167339
N Engl J Med. 2006 Aug 10;355(6):570-80
16899777
Cancer Res. 2005 Aug 15;65(16):7065-70
16103053
RNA. 2008 May;14(5):829-35
18367718
Mol Cell. 2007 Jul 6;27(1):91-105
17612493
Trends Biotechnol. 2008 Feb;26(2):70-6
18191262
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3903-8
18308936
Cancer Cell. 2006 Mar;9(3):189-98
16530703
Nucleic Acids Res. 2006 Jan 24;34(2):e9
16434699
Nat Genet. 2007 May;39(5):673-7
17401365
Science. 2007 Apr 27;316(5824):608-11
17463290
Methods. 2007 Oct;43(2):140-5
17889801
Cell. 2005 Mar 11;120(5):635-47
15766527
Development. 2005 Nov;132(21):4645-52
16224044
Methods. 2008 Jan;44(1):47-54
18158132
Nucleic Acids Res. 2004 Feb 25;32(4):e43
14985473
Cell Res. 2008 Mar;18(3):350-9
18270520
J Biol Chem. 2007 Aug 10;282(32):23716-24
17569667
Science. 2005 Sep 2;309(5740):1577-81
16141076
Cell. 2008 Mar 7;132(5):875-86
18329372
Cancer Res. 2004 Jun 1;64(11):3753-6
15172979
Nature. 2004 Nov 11;432(7014):226-30
15538371
Mol Cell Biol. 2007 Mar;27(5):1859-67
17194750
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2208-13
16452165
Cell. 1993 Dec 3;75(5):843-54
8252621
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18125-30
17116888
Int J Med Sci. 2008 Apr 03;5(2):73-9
18392144
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1556-62
16179643
Nature. 2007 Dec 13;450(7172):1096-9
18075594
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15805-10
17890317
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9667-72
17535905
Cancer Res. 2007 Aug 15;67(16):7713-22
17699775
Nucleic Acids Res. 2005 Nov 27;33(20):e179
16314309
Science. 2001 Oct 26;294(5543):858-62
11679671
Biochim Biophys Acta. 2008 Aug;1779(8):471-8
18194678
Birth Defects Res C Embryo Today. 2006 Jun;78(2):180-9
16847883
J Virol. 2008 Aug;82(16):8215-23
18550664
Oncogene. 2008 Jun 19;27(27):3845-55
18246122
BMC Genomics. 2007 Jun 15;8:172
17573962
Oncogene. 2006 Apr 20;25(17):2537-45
16331254
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2746-51
16477010
Nature. 2005 Jun 9;435(7043):834-8
15944708
Cancer Res. 2005 Nov 1;65(21):9628-32
16266980
Oncogene. 2008 Jul 17;27(31):4373-9
18372920
Cell. 2005 Jan 14;120(1):15-20
15652477
RNA. 2007 Jan;13(1):151-9
17105992
Science. 2001 Feb 16;291(5507):1304-51
11181995
J Mol Biol. 2006 May 12;358(4):983-96
16564540
Dev Biol. 2007 Oct 15;310(2):442-53
17765889
Cell. 2003 Dec 26;115(7):787-98
14697198
Science. 2007 Dec 21;318(5858):1931-4
18048652
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9
17242365
Nature. 2004 Oct 21;431(7011):931-45
15496913
J Virol. 2008 Feb;82(4):1946-58
18057241
Cancer Res. 2005 Jul 15;65(14):6029-33
16024602
Am J Hum Genet. 2007 Oct;81(4):829-34
17847008
Nature. 2008 Apr 17;452(7189):896-9
18368051
Ann Oncol. 2008 Jun;19(6):1053-9
18304967
Cancer Res. 2007 Nov 15;67(22):11001-11
18006846
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
16885212